Methods for treating leakage from a gastrointestinal site
The method addresses the challenge of gastrointestinal leakage by using a delivery matrix sealant with ciprofloxacin and ibuprofen to sustainably address infection and ischemia, improving surgical outcomes and reducing complications.
Patent Information
- Application Number
- PCT/IB2024/059346
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-09-28
- Filing Date
- 2024-09-25
- Publication Date
- 2025-04-03
AI Technical Summary
Current methods fail to effectively prevent and treat leakage from gastrointestinal sites, particularly anastomotic leaks, which are a significant complication in colorectal surgeries and have not seen significant improvement in leak rates over the past 40 years.
A method involving a delivery matrix sealant that combines ciprofloxacin and ibuprofen, delivered via a biologic or synthetic hydrogel, to address infection and ischemia at the gastrointestinal site, providing sustained release of the pharmacological agents for up to two weeks.
The method effectively prevents and treats leakage from gastrointestinal sites by providing sustained release of antibiotics and anti-inflammatory agents, reducing infection and ischemia, and improving patient outcomes by reducing hospital stay, mortality, and reoperation rates.